Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: BioCryst Pharmaceuticals Inc., 3 years.
BioCryst Pharmaceuticals Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
BioCryst Pharmaceuticals Inc. June 11, 202597.5%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 11, 2026 | BioCryst Pharmaceuticals Inc. | Grant or award | +15,294 | — | — |
| Jun 12, 2025 | BioCryst Pharmaceuticals Inc. | Grant or award | +12,500 | — | — |
| Jun 12, 2024 | BioCryst Pharmaceuticals Inc. | Grant or award | +6,820 | — | — |
| May 30, 2024 | BioCryst Pharmaceuticals Inc. | Open-market purchase | +7,861 | $6.36 | $49,996 |
| Jun 13, 2023 | BioCryst Pharmaceuticals Inc. | Grant or award | +16,745 | — | — |
| May 31, 2023 | BioCryst Pharmaceuticals Inc. | Grant or award | +1,360 | $8.27 | $11,247 |
| Feb 28, 2023 | BioCryst Pharmaceuticals Inc. | Grant or award | +1,271 | $8.85 | $11,248 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.